Home / Hematology
Hematology
| 1 min read
The Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG may have to open their wallets after they were fined a total of $5.7 million by competition regulators on Dec. 1 for alleged price-fixing of drugs for erectile dysfunction.
| 3 min read
Building off some earlier, promising research, a team of researchers at the National Cancer Institute (NCI) of the National Institutes of Health have found that the drug vorinostat, a histone deactylase inhibitor, may be able to cross the blood-brain barrier and stave off brain metastases—something that may be particularly welcome news to breast cancer patients.
| 1 min read
GenScript has signed a biology research collaboration with Roche Research & Development Center (RRDC) to provide assay development services for potential drug targets in line with Roche’s drug development portfolio.
| 3 min read
Ewing’s sarcoma is an often-deadly form of bone cancer that typically afflicts children and young adults, but it’s also one that might pose a little less threat thanks to researchers at Huntsman Cancer Institute (HCI) at the University of Utah, who have shed new light on the disease.
| 3 min read
Company acquires Seattle-based Gene Expression Laboratory and will provide Merck with genomic analysis services
| 3 min read
North Carolina State University and UNC Lineberger team up to combat cancer in man—and man’s best friend
| 3 min read
Virginia Commonwealth University researchers recently announced they have identified a gene that may play a key role in regulating tumor progression in neuroblastoma, a form of cancer usually found in young children. This particular culprit—and potential lead on developing a therapy to inhibit the expression of this gene—turns out to astrocyte elevated gene-1 (AEG-1).
| 3 min read
A new approach to stimulating immune cells enhances their anticancer activity, resulting in a powerful anti-tumor response in mice, according to a study by researchers at the National Cancer Institute, a part of the National Institutes of Health.
| 4 min read
A team at Harvard University and Massachusetts-based Advanced Cell Technology Inc. have taken another step forward in the development of technology for versatile, grow-in-a-dish transplant tissue, announcing that they have found a safe way to turn skin cells into stem cells.
| 3 min read
Clinical Data continues to push FCGR work with monoclonal antibodies forward, adding two new research partners to explore this pathway
| 3 min read
PerkinElmer and Accelrys announce software collaboration to enable single-cell imaging using high-content screening technology
| 2 min read
Researchers at the University of North Carolina at Chapel Hill School of Medicine and UNC Lineberger Comprehensive Cancer Center have found that defects in a gene called p18 prevents tumor-suppressor genes from controlling healthy cell proliferation, leading to cancer. According to the researchers, their discovery may lead to new test treatments for luminal-type tumors, which account for between 70 and 80 percent of all breast cancers.
